142 related articles for article (PubMed ID: 37775111)
1. Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study.
Heerfordt CK; Rønn C; Harboe ZB; Ingebrigtsen TS; Svorre Jordan A; Wilcke JT; Bonnesen B; Biering-Sørensen T; Sørensen R; Holler JG; Itenov TS; Johansen HK; Sivapalan P; Eklöf J; Jensen JS
BMJ Open Respir Res; 2023 Sep; 10(1):. PubMed ID: 37775111
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study.
Sicras-Mainar A; de Abajo FJ; Izquierdo-Alonso JL
Int J Chron Obstruct Pulmon Dis; 2020; 15():3291-3302. PubMed ID: 33328730
[TBL] [Abstract][Full Text] [Related]
4. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
[TBL] [Abstract][Full Text] [Related]
5. Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.
Sonnappa S; Martin R; Israel E; Postma D; van Aalderen W; Burden A; Usmani OS; Price DB;
PLoS One; 2017; 12(6):e0178112. PubMed ID: 28617814
[TBL] [Abstract][Full Text] [Related]
6. Hospitalization for chronic obstructive pulmonary disease and pneumonia: association with the dose of inhaled corticosteroids. A nation-wide cohort study of 52 100 outpatients.
Rønn C; Sivapalan P; Eklöf J; Kamstrup P; Biering-Sørensen T; Bonnesen B; Harboe ZB; Browatzki A; Kjærgaard JL; Meyer CN; Jensen TT; Johansson SL; Bendstrup E; Ulrik CS; Stæhr Jensen JU
Clin Microbiol Infect; 2023 Apr; 29(4):523-529. PubMed ID: 36503112
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
van der Molen T; Postma DS; Martin RJ; Herings RM; Overbeek JA; Thomas V; Miglio C; Dekhuijzen R; Roche N; Guilbert T; Israel E; van Aalderen W; Hillyer EV; van Rysewyk S; Price DB
BMC Pulm Med; 2016 May; 16(1):80. PubMed ID: 27184175
[TBL] [Abstract][Full Text] [Related]
8. Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies.
Sonnappa S; McQueen B; Postma DS; Martin RJ; Roche N; Grigg J; Guilbert T; Gouder C; Pizzichini E; Niimi A; Phipatanakul W; Chisholm A; Dandurand RJ; Kaplan A; Israel E; Papi A; van Aalderen WMC; Usmani OS; Price DB
J Allergy Clin Immunol Pract; 2018; 6(3):907-915.e7. PubMed ID: 28941668
[TBL] [Abstract][Full Text] [Related]
9. Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study.
Lee MC; Lee CH; Chien SC; Chang JH; She HL; Wang JY; Yu MC
Medicine (Baltimore); 2015 Oct; 94(42):e1723. PubMed ID: 26496284
[TBL] [Abstract][Full Text] [Related]
10. Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone.
Price DB; Henley W; Cançado JED; Fabbri LM; Kerstjens HAM; Papi A; Roche N; Şen E; Singh D; Vogelmeier CF; Barille S; Nudo E; Carter V; Skinner D; Vella R; Georges G
Int J Chron Obstruct Pulmon Dis; 2022; 17():355-370. PubMed ID: 35210765
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study.
Kendzerska T; Aaron SD; To T; Licskai C; Stanbrook M; Vozoris NT; Hogan ME; Tan WC; Bourbeau J; Gershon AS
Ann Am Thorac Soc; 2019 Oct; 16(10):1252-1262. PubMed ID: 31298938
[No Abstract] [Full Text] [Related]
12. Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids.
Guilbert TW; Colice G; Grigg J; van Aalderen W; Martin RJ; Israel E; Postma DS; Roche N; Phipatanakul W; Hillyer EV; Evans JM; Dolovich MB; Price DB;
J Allergy Clin Immunol Pract; 2017; 5(4):1040-1049.e4. PubMed ID: 28110057
[TBL] [Abstract][Full Text] [Related]
13. Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring
Heerfordt CK; Eklöf J; Sivapalan P; Ingebrigtsen TS; Biering-Sørensen T; Harboe ZB; Koefod Petersen J; Andersen CØ; Boel JB; Bock AK; Mathioudakis AG; Hurst JR; Kolekar S; Johansson SL; Bangsborg JM; Jarløv JO; Dessau RB; Laursen CB; Perch M; Jensen JS
Int J Chron Obstruct Pulmon Dis; 2023; 18():373-384. PubMed ID: 36974273
[TBL] [Abstract][Full Text] [Related]
14. Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study.
Lee JH; Park YH; Kang DR; Lee SJ; Lee MK; Kim SH; Yong SJ; Lee WY
Int J Chron Obstruct Pulmon Dis; 2020; 15():3397-3406. PubMed ID: 33402820
[TBL] [Abstract][Full Text] [Related]
15. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP
BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847
[TBL] [Abstract][Full Text] [Related]
16. The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging.
De Backer J; Vos W; Vinchurkar S; Van Holsbeke C; Poli G; Claes R; Salgado R; De Backer W
J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):88-99. PubMed ID: 25004168
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.
Martin RJ; Price D; Roche N; Israel E; van Aalderen WM; Grigg J; Postma DS; Guilbert TW; Hillyer EV; Burden A; von Ziegenweidt J; Colice G
NPJ Prim Care Respir Med; 2014 Oct; 24():14081. PubMed ID: 25297072
[TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
Thornton Snider J; Luna Y; Wong KS; Zhang J; Chen SS; Gless PJ; Goldman DP
Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
Suissa S; Dell'Aniello S; Ernst P
Lancet Respir Med; 2018 Nov; 6(11):855-862. PubMed ID: 30343028
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β
Wang MT; Lai JH; Huang YL; Liou JT; Cheng SH; Lin CW; Pan HY; Hsu YJ; Tsai CL
Chest; 2021 Oct; 160(4):1255-1270. PubMed ID: 34023320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
